PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis

Simple item page
dc.contributor.authorDawson R
dc.contributor.authorDiacon AH
dc.date.accessioned2014-07-07T12:26:15Z
dc.date.available2014-07-07T12:26:15Z
dc.date.issued2013
dc.descriptionPlease help populate SUNScholar with the full text of SU research output. Also - should you need this item urgently, please send us the details and we will try to get hold of the full text as quick possible. E-mail to scholar@sun.ac.za. Thank you.
dc.descriptionJournal Articles (subsidised)
dc.descriptionGeneeskunde en Gesondheidswetenskappe
dc.descriptionGeneeskundige Fisiologie
dc.identifier.citationExpert Opinion on Investigational Drugs
dc.identifier.citation22
dc.identifier.citation1
dc.identifier.citation6
dc.identifier.urihttp://hdl.handle.net/10019.1/93494
dc.publisherASHLEY PUBLICATIONS LTD, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEYCENTRAL, LONDON, ENGLAND, N3 1QB
dc.titlePA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis
Files
Collections
2013 - Research Outputs (Accredited)